2016
DOI: 10.1038/mtna.2015.50
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of MNK1b DNA Aptamers That Inhibit Proliferation in MDA-MB231 Breast Cancer Cells

Abstract: Elevated expression levels of eukaryotic initiation factor 4E (eIF4E) promote cancer development and progression. MAP kinase interacting kinases (MNKs) modulate the function of eIF4E through the phosphorylation that is necessary for oncogenic transformation. Therefore, pharmacologic MNK inhibitors may provide a nontoxic and effective anticancer strategy. MNK1b is a truncated isoform of MNK1a that is active in the absence of stimuli. Using in vitro selection, high-affinity DNA aptamers to MNK1b were selected fr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
46
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(51 citation statements)
references
References 45 publications
5
46
0
Order By: Relevance
“…Interestingly, the G-rich region containing the two non-standard nucleotides appeared to form a large loop on top of the second stem. This suggested the presence of some form of higher-level three-dimensional folding beyond simple base-pairing, such as G-quadruplex structures, as seen previously for other aptamers (30,31). …”
Section: Resultssupporting
confidence: 69%
“…Interestingly, the G-rich region containing the two non-standard nucleotides appeared to form a large loop on top of the second stem. This suggested the presence of some form of higher-level three-dimensional folding beyond simple base-pairing, such as G-quadruplex structures, as seen previously for other aptamers (30,31). …”
Section: Resultssupporting
confidence: 69%
“…3A), which have been reported to be associated with aptamer stability and cellular functions 24-26. The G-quadruplex structure in aptamer HL-1 was further confirmed with Thioflavin T staining (Fig.…”
Section: Resultssupporting
confidence: 56%
“…The relative expression was expressed as a ratio of the target gene to the control gene using the formula 2 -(∆∆Ct) , where ∆∆Ct=(Ct Target -Ct β-actin ) treatment -(Ct Target -Ct β-actin ) control . Relative expression was normalized and expressed as a ratio to the expression in the control group [24-26]. …”
Section: Methodsmentioning
confidence: 99%